Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
about
Reducing Overtreatment in Gynecologic Oncology: The Case for Less in Endometrial and Ovarian CancerSurveillance and Care of the Gynecologic Cancer SurvivorStratification of risk groups according to survival after recurrence in endometrial cancer patientsUse and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.Two cases of endocervical villoglandular adenocarcinoma: Support for conservative managementSerum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature reviewHigh-Grade Cervical Dysplasia following Radiation Therapy for Invasive Cervical Cancer: A Report of Four Cases.Patterns and utility of routine surveillance in high grade endometrial cancerLong-term mortality among women with epithelial ovarian cancer.Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers.Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAdded value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences.The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.Fertility-sparing surgery for early-stage cervical cancer.Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancerSEOM guidelines for cervical cancer.Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors.Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence: A Subanalysis.Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma.Gynaecological cancer follow-up: national survey of current practice in the UK.Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation.A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.Impact of molecular profiling on overall survival of patients with advanced ovarian cancer.The utility and management of vaginal cytology after treatment for endometrial cancer.Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer.A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers.Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement.Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.Evaluation of the indications for performing magnetic resonance imaging of the female pelvis at a referral center for cancer, according to the American College of Radiology criteria.Class I versus Class III radical hysterectomy in stage IB1 (tumor ≤ 2 cm) cervical cancer: a matched cohort study.Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.Should the annual pelvic examination go the way of annual cervical cytology?Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.Multimodality imaging of locally recurrent and metastatic cervical cancer: emphasis on histology, prognosis, and management.Vaginal Cytology Results in Follow-up of Endometrial Carcinoma After Hysterectomy.Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare.
P2860
Q26744528-232C0E69-F393-4261-84DE-20BDE25FB66DQ26799810-212D5E12-1804-4A45-9A6E-399E621EB99BQ33760521-66341FE9-E327-4682-8A66-5350938CE747Q33816983-A9B9A69D-6933-4F39-9A7F-FC6C7FC46610Q34480767-BBFBF226-614F-4E50-9FEA-D55CF04040A2Q35128002-C73122A3-FEE2-4E9A-8890-2568A2FBD7D1Q35388244-8234B2C3-6671-4B67-B66F-4356ED924CCCQ35726017-282FDC2D-FEAA-4819-9DD9-89CEEE44984DQ35793026-798F1ED8-6A27-4D56-9B27-2625D208B1A7Q35908816-E851DD26-5DE8-4AB0-ABEF-74592A096149Q35924450-3BE70FF4-F41D-4A38-B1B6-BD98FFFCB186Q36011137-4604BE8D-B89C-4618-8DF5-25BD158DB748Q36018699-8C442453-1529-4A62-B0DF-C317668988D6Q36039632-6C3E43F4-C4D2-4C3E-B0AF-5D55CF9D7ED1Q36102053-5E4A4E3B-4A24-4595-BA6D-732EFBB3B6EAQ36295667-B9334338-FE2B-4F41-A433-1747AC778153Q36400305-13552906-180C-48BB-BC1B-0969A13031DEQ36609765-7F5825DB-5643-4F2B-867A-257563F39DA8Q36922067-321A85F1-01B3-45B6-BBD8-81935E47FB80Q36923202-2511F0B1-A735-4015-9647-E9B4E100D5E9Q37065048-6D404F5D-B69B-47F3-834F-08AD012C41F2Q37121118-9AB9B5C1-42C4-4DF0-84F7-E643561A405CQ37160661-5D582364-F887-4C47-AC9B-1D2BC698935FQ37190190-C9E55E7F-936B-4AD9-A165-054D87571DA6Q37395946-0628F15B-E9D5-4FE1-85D7-6F1A76D5B53EQ37409836-387A3482-84F6-45F9-BD1F-CC3C8BC522B9Q37435187-BB23C6E5-B385-4AE7-9C86-BF2AE60379EAQ37457596-817F9DC9-4211-4207-B77C-4FB4E2A46964Q37536735-2CD48EC2-2D69-44DE-87FE-D578B5EA92A7Q37558633-E5740B2F-EDA2-4E24-9A66-19EDE7B7B01FQ37672594-F3627DA1-BB82-43FD-87A1-E56209D9DAFFQ37681208-907EB39E-014C-4B71-B956-43CC0884B0ECQ37695867-C78110CB-07A0-4489-B892-56CDC5FA1484Q37738090-C9F535F6-5C07-446E-A32E-947C762E304EQ38168282-48AAEA28-9CE3-4139-A7E7-32B666F243ABQ38254648-5E5BC856-4DE7-4D94-A4E5-1B0821DBD487Q38853681-7D88A814-851E-4E99-B545-2C84BB4FBA78Q38881050-D224A6A8-6D97-41C6-91CB-E6646459BB1BQ39637381-DC669168-C485-484C-8C16-470DEBCC6003Q40094845-9586DD1B-FF33-4ADB-BDC4-B9FBA6795FA5
P2860
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Posttreatment surveillance and ...... c Oncologists recommendations.
@ast
Posttreatment surveillance and ...... c Oncologists recommendations.
@en
Posttreatment surveillance and ...... c Oncologists recommendations.
@nl
type
label
Posttreatment surveillance and ...... c Oncologists recommendations.
@ast
Posttreatment surveillance and ...... c Oncologists recommendations.
@en
Posttreatment surveillance and ...... c Oncologists recommendations.
@nl
prefLabel
Posttreatment surveillance and ...... c Oncologists recommendations.
@ast
Posttreatment surveillance and ...... c Oncologists recommendations.
@en
Posttreatment surveillance and ...... c Oncologists recommendations.
@nl
P2093
P1476
Posttreatment surveillance and ...... c Oncologists recommendations.
@en
P2093
Barbara A Goff
Christine H Holschneider
Floor J Backes
Lynn P Parker
Michael Fung Kee Fung
Ritu Salani
Robert E Bristow
P304
P356
10.1016/J.AJOG.2011.03.008
P407
P577
2011-06-01T00:00:00Z